Citation: | Sun Zhongwei, Fan Yu, Bai Hongwei, et al. Relationship between metabolic rate of tacrolimus and BK virus infection early after renal transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(4): 278-282. doi: 10.3969/j.issn.1674-7445.2018.04.007 |
[1] |
HIRSCH HH, VINCENTI F, FRIMAN S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study[J]. Am J Transplant, 2013, 13(1): 136-145. DOI: 10.1111/j.1600-6143.2012.04320.x.
|
[2] |
SHENAGARI M, MONFARED A, EGHTEDARI H, et al. BK virus replication in renal transplant recipients: analysis of potential risk factors may contribute in reactivation[J]. J Clin Virol, 2017, 96:7-11. DOI: 10.1016/j.jcv.2017.09.004.
|
[3] |
GARD L, VAN DOESUM W, NIESTERS HGM, et al. A delicate balance between rejection and BK polyomavirus associated nephropathy; a retrospective cohort study in renal transplant recipients[J]. PLoS One, 2017, 12(6): e0178801. DOI: 10.1371/journal.pone.0178801.
|
[4] |
CHEN L, PRASAD GVR. CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment[J]. Pharmgenomics Pers Med, 2018, 11:23-33. DOI: 10.2147/PGPM.S107710.
|
[5] |
HAUFROID V, WALLEMACQ P, VANKERCKHOVE V, et al. CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study[J]. Am J Transplant, 2006, 6(11): 2706-2713. doi: 10.1111/ajt.2006.6.issue-11
|
[6] |
THÖLKING G, FORTMANN C, KOCH R, et al. The tacrolimus metabolism rate influences renal function after kidney transplantation[J]. PLoS One, 2014, 9(10): e111128. DOI: 10.1371/journal.pone.0111128.
|
[7] |
HUMAR A, MICHAELS M, AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation[J]. Am J Transplant, 2006, 6(2): 262-274. doi: 10.1111/ajt.2006.6.issue-2
|
[8] |
LI D, ZHANG GL, LOU YQ, et al. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups[J]. J Clin Pharm Ther, 2007, 32(1): 89-95. doi: 10.1111/jcp.2007.32.issue-1
|
[9] |
DALIANIS T, RAMQVIST T, ANDREASSON K, et al. KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research[J]. Semin Cancer Biol, 2009, 19(4): 270-275. DOI: 10.1016/j.semcancer.2009.04.001.
|
[10] |
HIRSCH HH, KNOWLES W, DICKENMANN M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients[J]. N Engl J Med, 2002, 347(7): 488-496. doi: 10.1056/NEJMoa020439
|
[11] |
NICKELEIT V, HIRSCH HH, ZEILER M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class Ⅱ expression and rejection in a puzzling game[J]. Nephrol Dial Transplant, 2000, 15(3): 324-332. doi: 10.1093/ndt/15.3.324
|
[12] |
张鑫, 刘志红, 郑敬民, 等.细胞色素P450 3A5和多药耐药基因1基因多态性在肾移植患者他克莫司血药浓度监测中的应用[J].肾脏病与透析肾移植杂志, 2004, 13(4): 313-317. DOI: 10.3969/j.issn.1006-298X.2004.04.003.
ZHANG X, LIU ZH, ZHENG JM, et al. CYP 3A 5 and MDR1 gene polymorphisms is associated with pharmacokinetic variation of tacrolimus in renal transplant patients[J]. Chin J Nephrol Dial Transplant, 2004, 13(4): 313-317. DOI: 10.3969/j.issn.1006-298X.2004.04.003.
|
[13] |
LIN YS, DOWLING AL, QUIGLEY SD, et al. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism[J]. Mol Pharmacol, 2002, 62(1): 162-172. doi: 10.1124/mol.62.1.162
|
[14] |
HAN N, HA S, YUN HY, et al. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation[J]. Basic Clin Pharmacol Toxicol, 2014, 114(5): 400-406. DOI: 10.1111/bcpt.12176.
|
[15] |
THÖLKING G, SCHMIDT C, KOCH R, et al. Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation[J]. Sci Rep, 2016, 6:32273. DOI: 10.1038/srep32273.
|
[16] |
范宇, 石炳毅, 钱叶勇, 等.肾移植术后BK病毒感染对移植肾功能影响的临床研究[J].器官移植, 2018, 9(1): 51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.
FAN Y, SHI BY, QIAN YY, et al. Clinical study on the effect of BK virus infection on renal allograft function after renal transplantation[J]. Organ Transplant, 2018, 9(1): 51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.
|
[17] |
GINEVRI F, DE SANTIS R, COMOLI P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches[J]. Transplantation, 2003, 75(8):1266-1270. doi: 10.1097/01.TP.0000061767.32870.72
|